What is Movano Health?
[Movano Health](https://registry.deploy.report/companies/movano-health) is the operating company behind the [Evie Ring](https://registry.deploy.report/models/movano-evie-ring), a smart ring biometric positioned within the biometric cluster's ring sub-cohort. Per registry verification: company operates as Movano Health; Evie Ring is the consumer-shipped product; per [consumer surface](https://deploy.report/price/movano-evie-ring) the ring operates at consumer retail pricing tier. CRITICAL CORPORATE-STATE-SHIFT CAP-FLAG: per registry references to Corvex + reverse merger, Movano Health operates within a corporate-state-shift via reverse merger structure (verified per registry framing); specific reverse-merger mechanics + timing + post-merger entity scope + Corvex Software corporate-state-shift framing operate at lower verification posture pending primary-source confirmation. Per [DEPLOY's biometric cluster framework](/explainers/biometric), Movano Health Evie Ring operates within the ring sub-cohort alongside Oura + Whoop + RingConn + Ultrahuman + Happy Ring; specific ring-sub-cohort archetype positioning (FDA-clearance posture + subscription-model + commercial-deployment maturity) cap-flagged pending primary-source verification of Movano-specific claim depth.
CRITICAL CORPORATE-STATE-SHIFT CAP-FLAG: reverse merger via Corvex
Per registry-surface references on the Movano Health entity page, Movano operates within a corporate-state-shift via reverse merger structure. The registry surfaces "Corvex" and "reverse merger" as part of the Movano corporate-state framing. Per cap-flag-as-trust-signal, the reverse-merger structure is verified at the registry-framing level; specific mechanics + timing + post-merger corporate scope operate at lower verification posture pending primary-source confirmation. SEC primary-source verification (8-K + S-1 + proxy statements) would resolve the specific reverse-merger transaction structure + timing + post-merger entity scope at primary-source depth. Trade-press coverage of biometric ring sub-cohort entries doesn't typically surface reverse-merger structures with verification depth.
Lifecycle-flip framing: editorially distinctive verification-posture work
The reverse-merger structure surfaces a structurally distinct editorial position from the broader biometric ring sub-cohort. Other ring sub-cohort entities operate clean corporate-state positions per existing entity anchor framings (Oura independent venture + RingConn independent venture + Ultrahuman independent venture + Happy Ring independent venture + Whoop independent venture). Movano Health operates at structurally distinct corporate-state position within the ring sub-cohort: a reverse-merger structure surfaces lifecycle-flip dynamics that aren't present in the independent-venture cohort entries. The lifecycle-flip framing is editorially distinctive verification-posture work per the framework discipline.
Evie Ring: consumer-shipped at retail pricing tier
Per registry verification, Evie Ring is the consumer-shipped Movano Health product. The Evie Ring operates at consumer retail pricing tier per the consumer surface. Specific product feature claims + FDA clearance posture + commercial deployment scope + AI-substance tier all operate at lower verification posture pending primary-source confirmation. The verified entity scope (Movano Health company + Evie Ring product registered at registry surface) is load-bearing; specific claims operate at honest cap-flag pending primary-source verification.
Specific claim depth cap-flagged pending primary-source verification
Multiple specific claim categories operate at lower verification posture pending primary-source confirmation. Specific feature claims (heart rate + sleep tracking + temperature + period tracking + AI insights) at primary-source depth pending Movano company communications + product documentation verification. FDA clearance posture specific 510(k) or other FDA clearance scope at primary-source verification depth pending FDA database confirmation. Commercial deployment scope specific commercial deployment scale + customer count + retail channel coverage at primary-source verification depth. AI-substance tier specific AI integration (generative vs adaptive-algorithmic vs rule-based) at primary-source verification depth. The cap-flag pattern operates per DEPLOY's framework: what's verified at the depth where it's verified; what's claimed at the depth where it operates.
Ring sub-cohort positioning within biometric cluster
Per the biometric cluster framework, Movano Health Evie Ring anchors a ring sub-cohort entry. Within the ring sub-cohort verified-vs-claimed framework worked examples: RingConn AHI 90.7%-claimed but NOT FDA-cleared; Happy Ring dual FDA 510(k) clearances K240236 + K242224; Ultrahuman market-access-redesigned (US blocked Oct 21 2025 → restored Mar 24 2026 via Ring Pro unibody redesign); Oura purchase + membership commercial model; Whoop subscription-only band exemplar. Movano Health Evie Ring's reverse-merger corporate-state framing surfaces lifecycle-flip dynamics distinct from independent-venture sub-cohort positioning.
Movano Health: ring sub-cohort entity within biometric cluster
Movano Health is the operating company behind the Evie Ring, a smart ring biometric positioned within the biometric cluster's ring sub-cohort alongside Oura + Whoop + RingConn + Ultrahuman + Happy Ring. Per consumer surface, Evie Ring operates at consumer retail pricing tier.
The verified entity scope per registry state: Movano Health is the canonical operating company entity; Evie Ring is the consumer-shipped product. The remainder of the editorial scope at this entity carries an active cap-flag for the corporate-state-shift framework that the registry references but verification at primary-source depth has not landed.
CRITICAL CORPORATE-STATE-SHIFT CAP-FLAG: reverse merger via Corvex
Per registry-surface references on the Movano Health entity page, Movano operates within a corporate-state-shift via reverse merger structure. The registry surfaces "Corvex" and "reverse merger" as part of the Movano corporate-state framing. Per cap-flag-as-trust-signal, the reverse-merger structure is verified at the registry-framing level; specific mechanics + timing + post-merger corporate scope operate at lower verification posture pending primary-source confirmation:
- Reverse-merger structure verified per registry framing: Movano Health corporate-state operates within a reverse-merger structure involving Corvex. The registry-surface reference is the load-bearing primary-source-anchored verification at this depth.
- Specific reverse-merger mechanics cap-flagged: typical reverse-merger structures involve a public shell entity merging with a private operating company. Specific transaction structure (public-shell-becomes-private vs private-becomes-public vs name-change-mechanics) operates at lower verification posture pending SEC primary-source confirmation (8-K + S-1 + proxy statements).
- Specific timing cap-flagged: trade-press coverage references late-2025/early-2026 timing for the reverse-merger close; specific close date + filing dates operate at lower verification posture pending SEC primary-source confirmation.
- Post-merger corporate scope cap-flagged: post-merger entity scope (which corporate entity continues + which dissolves + how the ticker symbol + which company name surfaces commercially + how product-line continuity operates) all cap-flagged at honest-not-known depth pending primary-source verification.
Per DEPLOY's framework, the corporate-state-shift framing matters editorially at the lifecycle-flip layer. Trade-press coverage of biometric ring sub-cohort entries doesn't typically surface reverse-merger structures with verification depth; the framework reads the corporate-state-shift state as editorial signal at the entity-verification layer.
The lifecycle-flip editorial framing
The reverse-merger structure surfaces a structurally distinct editorial position from the broader biometric ring sub-cohort. Other ring sub-cohort entities operate clean corporate-state positions per existing entity anchor framings:
- Oura Ring: independent venture; '178 patent holder + plaintiff in ITC dispute; established Finnish corporate-state continuity.
- RingConn (Gen 2 / Gen 3): independent venture; settled-licensed cleanly with Oura on '178 patent.
- Ultrahuman Ring (Air / Pro): independent venture; US market access blocked October 21, 2025 → restored March 24, 2026 via Ring Pro unibody redesign.
- Happy Ring: independent venture; Happy Health corporate-state continuing; $60M Series A August 2022; commercially active across 48 states.
- Whoop: independent venture; $10.1B Series G March 2026 lead Collaborative Fund.
Movano Health operates at structurally distinct corporate-state position within the ring sub-cohort: a reverse-merger structure surfaces lifecycle-flip dynamics that aren't present in the independent-venture cohort entries. The lifecycle-flip framing is editorially distinctive verification-posture work per cap-flag-as-trust-signal: the framework reads corporate-state-shift states honestly with the verification depth surfaced explicitly.
Per DEPLOY's how-deploy-verifies methodology editorial, the reverse-merger framing surfaces multiple primary-source verification dependencies at once. The transaction structure operates at SEC primary-source verification posture. The product-line continuity operates at company primary-source verification posture. The post-merger commercial trajectory operates at trade-press observational depth pending primary-source confirmation.
Evie Ring: consumer ring product scope
Per registry verification, Evie Ring is the consumer-shipped Movano Health product. The Evie Ring operates at consumer retail pricing tier per the consumer surface. Per cap-flag-as-trust-signal, specific product feature claims + FDA clearance posture + commercial deployment scope + AI-substance tier all operate at lower verification posture pending primary-source confirmation:
- Product positioning verified: smart ring biometric within the consumer ring sub-cohort.
- Product positioning cap-flagged: specific feature claims (heart rate + sleep tracking + temperature + period tracking + AI insights) at primary-source depth pending Movano company communications + product documentation verification.
- FDA clearance posture cap-flagged: specific 510(k) or other FDA clearance scope for any health-claim features at primary-source verification depth pending FDA database confirmation.
- Commercial deployment scope cap-flagged: specific commercial deployment scale + customer count + retail channel coverage at primary-source verification depth pending company communications.
- AI-substance tier cap-flagged: specific AI integration (generative vs adaptive-algorithmic vs rule-based) at primary-source verification depth.
The cap-flag pattern operates per DEPLOY's framework. The verified entity scope (Movano Health company + Evie Ring product registered at registry surface) is load-bearing; specific feature + clearance + deployment + AI claims operate at lower verification posture pending primary-source confirmation. The framework reads what's verified at the depth where it's verified.
Cohort positioning: ring sub-cohort entry
Per the biometric cluster framework, Movano Health Evie Ring anchors:
- Ring sub-cohort entry: alongside Oura + Whoop + RingConn + Ultrahuman + Happy Ring; verified entity at the cluster-framework level.
- Reverse-merger corporate-state framing: structurally distinct from independent-venture corporate states across the ring sub-cohort; reverse-merger structure surfaces lifecycle-flip dynamics.
- Verified retail product: Evie Ring consumer-shipped at retail pricing tier per consumer surface.
- Cap-flagged claim depth: specific feature + clearance + deployment + AI-substance claims operate at lower verification posture pending primary-source confirmation.
Contrast within ring sub-cohort:
- RingConn (Gen 2 / Gen 3): $279 subscription-free; AHI 90.7%-claimed but NOT FDA-cleared; ITC settled-licensed (NOT banned per Agent A correction).
- Ultrahuman Ring (Air / Pro): ~$349 hardware + subscription-augmented; AFib via FibriCheck third-party (NOT native cleared); US market access blocked Oct 21 2025 → restored Mar 24 2026.
- Happy Ring: service-gated (NO retail price; insurer-billed Happy Sleep); dual FDA 510(k) clearances K240236 + K242224.
- Oura Ring: hardware purchase + $5.99/mo membership; '178 patent holder.
- Whoop (band cohort exemplar adjacent to ring sub-cohort): subscription-only $239/yr + $239 hardware = ~$478 Year 1.
- Movano Health Evie Ring: reverse-merger corporate-state; retail-positioned consumer ring; specific claim depth cap-flagged.
Consumer pricing surface for Movano Evie Ring is LIVE at deploy.report/price/movano-evie-ring. Registry institutional depth at Movano Health registry company + Evie Ring registry model.
For the canonical biometric cluster context, see the biometric cluster. For the ring sub-cohort verified-vs-claimed framework worked examples, see what is RingConn (AHI-claimed-not-cleared) + what is Happy Ring (dual FDA clearances). For the methodology editorial canonical reference where the cap-flag discipline operates, see how DEPLOY verifies. For the canonical category umbrella, see what is physical AI. For methodology canonical references applicable to Movano Health: verified-vs-claimed at within-entity granularity (within-Movano reverse-merger corporate-state + Evie Ring feature claims + FDA clearance posture cap-flag depth) + the 9-tier source-quality rubric (SEC reverse-merger + Corvex primary-source classification).
Sources: Source: DEPLOY registry + biometric cluster framework + per-maker public communications + ring sub-cohort verified-vs-claimed framework. Ring sub-cohort archetype + corporate-state framework.
Frequently Asked Questions
What is Movano Health?
Movano Health is the operating company behind the Evie Ring, a smart ring biometric positioned within the biometric cluster's ring sub-cohort. Per registry verification: company operates as Movano Health; Evie Ring is the consumer-shipped product at retail pricing tier per consumer surface. CRITICAL CORPORATE-STATE-SHIFT CAP-FLAG: per registry references to Corvex + reverse merger, Movano Health operates within a corporate-state-shift via reverse merger structure; specific transaction mechanics + timing + post-merger entity scope cap-flagged pending SEC primary-source confirmation.
Did Corvex acquire Movano?
Per registry-surface references on the Movano Health entity page, Movano operates within a corporate-state-shift via reverse merger structure involving Corvex. The reverse-merger structure is verified at the registry-framing level. Per cap-flag-as-trust-signal, specific reverse-merger mechanics (public-shell-becomes-private vs private-becomes-public vs name-change-mechanics) + timing + post-merger entity scope operate at lower verification posture pending SEC primary-source confirmation (8-K + S-1 + proxy statements). Trade-press coverage references late-2025/early-2026 timing for the reverse-merger close; specific close date + filing dates cap-flagged.
What is the Evie Ring?
Evie Ring is Movano Health's consumer-shipped smart ring biometric, positioned within the biometric cluster's ring sub-cohort. The Evie Ring operates at consumer retail pricing tier per the consumer surface. Per cap-flag-as-trust-signal, specific product feature claims + FDA clearance posture + commercial deployment scope + AI-substance tier all operate at lower verification posture pending primary-source confirmation. The verified entity scope is the product existence at the registry surface and the consumer retail pricing position; specific feature + clearance + deployment + AI claims at honest cap-flag pending primary-source verification.
Is the Evie Ring FDA-cleared?
FDA clearance posture cap-flagged pending primary-source verification per cap-flag-as-trust-signal. Specific 510(k) or other FDA clearance scope for any Evie Ring health-claim features operates at primary-source verification depth pending FDA database confirmation. Per DEPLOY's biometric cluster framework + ring sub-cohort verified-vs-claimed framework worked examples: RingConn AHI 90.7%-claimed but NOT FDA-cleared; Happy Ring dual FDA 510(k) clearances K240236 + K242224; Ultrahuman AFib via FibriCheck third-party NOT native cleared. The framework reads ring sub-cohort FDA clearance posture at primary-source verification depth; Evie Ring specific clearance scope pending primary-source confirmation.
How does the Evie Ring compare to Oura?
Specific feature + clearance + deployment + AI claim comparisons cap-flagged pending primary-source verification of Movano-specific claim depth per DEPLOY's framework. Verified comparison axes at registry-framing level: both Movano Health Evie Ring + Oura Ring operate within the ring sub-cohort of the biometric cluster; Movano operates reverse-merger corporate-state framing while Oura operates independent-venture corporate-state continuity; Oura Ring is the '178 patent holder + plaintiff in the ITC dispute that involved RingConn (settled-licensed) and Ultrahuman (blocked then restored). Per cap-flag-as-trust-signal discipline, specific Evie Ring vs Oura Ring feature comparisons at sleep tracking + heart rate + AI insights + period tracking depth operate at lower verification posture pending primary-source confirmation.
Why does the reverse-merger framing matter editorially?
Per DEPLOY's how-deploy-verifies methodology editorial, corporate-state-shift framings surface multiple primary-source verification dependencies at once. The reverse-merger structure surfaces a structurally distinct editorial position from the broader biometric ring sub-cohort (other ring sub-cohort entities operate independent-venture corporate-state positions). The lifecycle-flip framing is editorially distinctive verification-posture work: the transaction structure operates at SEC primary-source verification posture; the product-line continuity operates at company primary-source verification posture; the post-merger commercial trajectory operates at trade-press observational depth pending primary-source confirmation. Trade-press coverage of biometric ring sub-cohort entries doesn't typically surface reverse-merger structures with verification depth; the framework reads the corporate-state-shift state as editorial signal at the entity-verification layer.
Movano Health verified as operating company behind Evie Ring smart ring biometric within biometric cluster's ring sub-cohort. Movano Health registered at /companies/movano-health; Evie Ring registered at /models/movano-evie-ring; consumer surface at /price/movano-evie-ring 200 LIVE at retail pricing tier. CRITICAL CORPORATE-STATE-SHIFT CAP-FLAG: per registry-surface references to Corvex + reverse merger, Movano operates within a corporate-state-shift via reverse merger structure (verified at registry-framing level). Specific reverse-merger mechanics + timing + post-merger corporate scope cap-flagged pending SEC primary-source confirmation (8-K + S-1 + proxy statements would resolve transaction structure + timing + post-merger entity scope). Trade-press references late-2025/early-2026 timing. Specific Evie Ring claim categories cap-flagged pending primary-source verification: feature claims (heart rate + sleep tracking + temperature + period tracking + AI insights); FDA clearance posture; commercial deployment scope; AI-substance tier. Ring sub-cohort positioning verified alongside Oura + Whoop + RingConn + Ultrahuman + Happy Ring; reverse-merger corporate-state framing structurally distinct from independent-venture cohort entries; lifecycle-flip framing is editorially distinctive verification-posture work per cap-flag-as-trust-signal discipline. How DEPLOY verifies →
Continue reading
What is RingConn?
Subscription-free ring archetype; AHI 90.7%-claimed but NOT FDA-cleared; sharp verified-vs-claimed counterpoint to Happy Ring's actual clearances.
Read article →
What is Happy Ring?
FDA-cleared + service-gated ring; dual K240236 + K242224 clearances; canonical verified-vs-claimed counterpoint within ring sub-cohort.
Read article →
The biometric cluster
Biometric cohort framework; ring sub-cohort archetypes + verified-vs-claimed framework at form-factor-cell granularity.
Read article →
How DEPLOY verifies
Methodology editorial canonical reference; four-tier verification protocol + cap-flag convention + canonical worked examples.
Read article →
Compare alternatives
Movano Health registry companyEvie Ring registry modelEvie Ring consumer price pageBiometric cluster
More in biometric wearables